These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2136044)

  • 1. Making information work.
    Scialli AR
    Reprod Toxicol; 1990; 4(4):249-50. PubMed ID: 2136044
    [No Abstract]   [Full Text] [Related]  

  • 2. Identifying teratogens: the tyranny of lists.
    Scialli AR
    Reprod Toxicol; 1997; 11(4):555-9. PubMed ID: 9241676
    [No Abstract]   [Full Text] [Related]  

  • 3. Making information work. Or "Let us not throw the baby out with the bathwater".
    Sullivan FM
    Reprod Toxicol; 1991; 5(4):393-4. PubMed ID: 1806146
    [No Abstract]   [Full Text] [Related]  

  • 4. Methods of evaluating the alleged teratogenicity of environmental agents.
    Brent RL
    Prog Clin Biol Res; 1985; 163C():191-5. PubMed ID: 3991621
    [No Abstract]   [Full Text] [Related]  

  • 5. Teratology Society 1998 Public Affairs Committee Symposium: the new thalidomide era: dealing with the risks.
    Friedman JM; Kimmel CA
    Teratology; 1999 Feb; 59(2):120-3. PubMed ID: 10069442
    [No Abstract]   [Full Text] [Related]  

  • 6. Reproductive and developmental toxicity testing: from in vivo to in vitro.
    Brown ES; Jacobs A; Fitzpatrick S
    ALTEX; 2012; 29(3):333-9. PubMed ID: 23019687
    [No Abstract]   [Full Text] [Related]  

  • 7. Teratology information--a new effort.
    Scialli AR
    Reprod Toxicol; 1991; 5(5):395-6. PubMed ID: 1806147
    [No Abstract]   [Full Text] [Related]  

  • 8. Human teratogens: update 2010.
    Holmes LB
    Birth Defects Res A Clin Mol Teratol; 2011 Jan; 91(1):1-7. PubMed ID: 21254353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report of the Teratology Society Public Affairs Committee symposium on FDA classification of drugs.
    Friedman JM
    Teratology; 1993 Jul; 48(1):5-6. PubMed ID: 8102499
    [No Abstract]   [Full Text] [Related]  

  • 10. Evolving knowledge of the teratogenicity of medications in human pregnancy.
    Adam MP; Polifka JE; Friedman JM
    Am J Med Genet C Semin Med Genet; 2011 Aug; 157C(3):175-82. PubMed ID: 21766440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teratology public affairs committee position paper: Pregnancy labeling for prescription drugs: Ten years later.
    Public Affairs Committee of the Teratology Society
    Birth Defects Res A Clin Mol Teratol; 2007 Sep; 79(9):627-30. PubMed ID: 17663419
    [No Abstract]   [Full Text] [Related]  

  • 12. Formation of the Organization of Teratology Information Services (OTIS). The OTIS Executive Committee.
    O'Brien J; Conover B; Frias J; Koren G; Quinn D; Robert E; Rosenwasser S
    Reprod Toxicol; 1991; 5(5):463. PubMed ID: 1806156
    [No Abstract]   [Full Text] [Related]  

  • 13. The Food and Drug Administration drug registration and listing system.
    Slavin M
    Drug Inf J; 1975; 9(2-3):239-40. PubMed ID: 10236978
    [No Abstract]   [Full Text] [Related]  

  • 14. Knowledge transfer and translation: examining how teratogen information is disseminated.
    Shahin I; Einarson A
    Birth Defects Res A Clin Mol Teratol; 2011 Nov; 91(11):956-61. PubMed ID: 21948595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA, alliance work to improve health information access.
    FDA Consum; 2004; 38(5):7. PubMed ID: 15595138
    [No Abstract]   [Full Text] [Related]  

  • 16. The Food and Drug Administration Information Center on adverse reactions and hazards.
    Saiger GL
    Pharmakotherapia; 1965; 2(2):124-8. PubMed ID: 5875220
    [No Abstract]   [Full Text] [Related]  

  • 17. Some experiences relating to food safety.
    Mrak EM
    Environ Qual Saf; 1976; 5():197-207. PubMed ID: 829667
    [No Abstract]   [Full Text] [Related]  

  • 18. Retinoic acid: a familiar teratogen.
    Hand JL
    Pediatr Dermatol; 2012; 29(6):774-6. PubMed ID: 23106679
    [No Abstract]   [Full Text] [Related]  

  • 19. Frances Kelsey honored for FDA legacy: award notes her work on thalidomide, clinical trials.
    Kuehn BM
    JAMA; 2010 Nov; 304(19):2109-10, 2112. PubMed ID: 21081717
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug labeling for teratogenicity: requirements of the U.S. Food and Drug Administration.
    Kelsey FO
    Prog Clin Biol Res; 1985; 163C():155-9. PubMed ID: 3991617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.